US FDA is approved by Cellistroin Omlyclo ® (Omarizumab-IGEC) as the first and only bioluka with a replacement of the referenced Xolair ®

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.